Though its specificity remains partly unclear, the authors showed efficacy in a NIK-dependent MM cell line using a general NF-κB gene reporter assay readout, with no significant inhibition in two NIK-independent MM cell lines. Here, MAP3K14 is linked to Miyoshi myopathy.